Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
UAB 1923: A Phase 2 Front-Line PET/CT-2 Response-Adapted Brentuximab Vedotin and Nivolumab Incorporated and Radiation-Free Management of Early Stage Classical Hodgkin Lymphoma (cHL) study
Grant
Overview
Affiliation
Overview
Awarded By
City of Hope
Total Award Amount
177075.00
Direct Costs
136212.00
Sponsor Award Id
Affiliation
Contributor
Amitkumar Mehta M.D.
Principal Investigator
Gaurav Goyal
Investigator
Luciano Costa M.D., Ph.D.
Investigator
Mayur Narkhede
Investigator
Pankit Vachhani
Investigator